Rachel Handy

Rachel is the VP of Quality Assurance at Eleusis. Rachel has over 25 years of experience in the pharmaceutical industry having held positions within early discovery through to late-stage clinical development with a breadth of knowledge to ensure that quality and data integrity runs through the core of Eleusis’ functions. Prior to joining Eleusis Rachel has worked for Merck, Astra Zeneca, Cambridge Antibody Technology, Ferring and Vantia. Most recently Rachel managed her own consultancy company and assisted a variety of biotech companies in clinical and quality.

Rachel received her PhD in Pharmacology and BSc(Hons) in Pharmacology with Toxicology from the University of London (King’s).